BGC-1614

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameBGC-1614
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Synthetic peptide > Circular polypeptide
Mechanisms of ActionNectin-4 binders
TargetsNectin-4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBrightgene Bio-Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrightgene Bio-Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A